Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Morgan Stanley

10 Biggest Price Target Changes For Monday

Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.

Benzinga

Morning Brief: Top Financial Stories Dominating on Monday, May 9

CNBC Ford Motor Selling 8M Shares Of Rivian Automotive

Benzinga

Elon Musk’s takeover financing deal could clip Twitter’s wings

The Tesla tycoon’s complex bid for the social media platform will load the tech firm with debt

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Florida pension fund sues Elon Musk and Twitter to stop buyout

The class-action lawsuit argues that the deal cannot close before 2025

The Guardian - US

Looking At Morgan Stanley's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Morgan Stanley (NYSE:MS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Check Out What Whales Are Doing With Visa

A whale with a lot of money to spend has taken a noticeably bearish stance on Visa. Looking at options history for Visa (NYSE:V) we detected 11 strange trades.

Benzinga

Looking At Moderna's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

'Still A Second-Half Story': Twilio Analysts React To Mixed Q1 Earnings

Twilio Inc (NYSE: TWLO) shares dropped 2.7% on Thursday after the company reported conservative second-quarter guidance.

Benzinga

Check Out What Whales Are Doing With BMY

Someone with a lot of money to spend has taken a bullish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Check Out What Whales Are Doing With MRNA

Benzinga

Wall Street Isn’t Ready for the Crackdown Coming Its Way

Federal investigations into questionable trading practices are on the rise—and the fate of Bill Hwang and his firm, Archegos, may await others in the finance industry.

Businessweek

Caesars Entertainment Whale Trades For May 04

Someone with a lot of money to spend has taken a bearish stance on Caesars Entertainment (NASDAQ:CZR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $145.00 to $132.00. Shares of Catalent are trading up 1.11% over the last 24 hours, at $101.06 per share. A move to $132.00 would account for a 30.62% increase from the current…

Benzinga

4 Starbucks Analysts On Q2 Earnings: Brewing China Concerns, Strong US Demand And More

Starbucks shares were rallying Wednesday after the coffee chain reported a second-quarter sales beat. The quarter was helped by strong growth and momentum in the North American segment. The big headwind facing the company is the impact of the China region, which analysts highlighted after the print.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

MGM Resorts Analysts React To Q1 Earnings Beat, LeoVegas Acquisition, Macau Weakness

MGM Resorts International (NYSE: MGM) shares traded lower by 3.5% on Tuesday after the company reported first-quarter earnings and revenue beats but a quarterly drop in Las Vegas Strip occupancy.

Benzinga

Here's Why Morgan Stanley Remained Bullish On Nvidia

Morgan Stanley analyst Joseph Moore reinstated NVIDIA Corp (NASDAQ:NVDA) with an Equal-Weight and a $217 price target. The price target implies an upside of 11.9%. Moore observes that Nvidia has "differentiated" offerings in the cloud and artificial intelligence and a leading position in gaming. Moore also highlighted concerns about a slowdown in gaming and its…

Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Chegg: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Chegg (NYSE:CHGG) and lower its price target from $37.00 to $20.00. Shares of Chegg are trading down 29.92% over the last 24 hours, at $17.50 per share. A move to $20.00 would account for a 14.25% increase from the current…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

10 Biggest Price Target Changes For Tuesday

Morgan Stanley cut Expedia Group, Inc. (NASDAQ: EXPE) price target from $215 to $210. Expedia shares rose 0.1% to close at $174.81 on Monday.

Benzinga

Looking At AbbVie's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 10 strange trades.

Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Qorvo: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Qorvo (NASDAQ:QRVO) and lower its price target from $150.00 to $127.00. Shares of Qorvo are trading up 1.94% over the last 24 hours, at $115.99 per share. A move to $127.00 would account for a 9.49% increase from the current…

Benzinga

10 Biggest Price Target Changes For Monday

Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading.

Benzinga

Here's How Much $100 Invested In Morgan Stanley 10 Years Ago Would Be Worth Today

Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 5.97% on an annualized basis producing an average annual return of 17.53%. Currently, Morgan Stanley has a market capitalization of $143.39 billion.

Benzinga

Why Are Accolade Shares Down Over 40% Today

Accolade Inc (NASDAQ:ACCD) shares plunged almost 50% after disappointing Q4 FY22 earnings and FY23 guidance. Q4 FY22 revenue increased 58% Y/Y to $93.8 million, beating the consensus of $91.57 million. The company reported a wider net loss of $(34.56) million compared to $(4.73) million a year ago. EPS loss came at $(0.51)…

Benzinga

10 Biggest Price Target Changes For Friday

Morgan Stanley lowered Apple Inc. (NASDAQ: AAPL) price target from $210 to $195. Apple shares fell 2.6% to $159.25 in pre-market trading.

1 … 66 67 68 69

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations